The French National Agency of Drug Safety and Health Products has refused the renewal of the derogation requested by a machine perfusion solution provider to continue to sell its perfusion solution KPS-1® in France without a CE mark. As a result, KPS-1 “…can not be placed on the market or put into service in France…” until that provider obtains a CE mark for its product.

Bridge to Life stands ready to supply French hospitals with CE-marked Belzer MPS® (UW Machine Perfusion Solution) for use as a replacement for KPS-1®*. Belzer MPS may be identified under an alternate name “MaPerSol.”

* KPS-1® is a registered trademark of Lifeline Scientific, Inc.